This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Double-Blind Experimental Trial

R. K. WINKELMANN, MD; ROBERT R. KIERLAND, MD; HAROLD O. PERRY, MD; SIGFRID A. MULLER, MD

Arch Dermatol. 1965;91(1):66-69.

Abstract
Thirty-two patients with scleroderma were treated with either sodium dextrothyroxine, 8 mg per day, or a placebo in an experimental double-blind study. No side effects were encountered. Judged on a clinical and laboratory basis, there was no difference between these two forms of therapy in their effect on scleroderma. It is suggested that objective evidence such as esophageal motility patterns provides the best basis for judgment as to the course of scleroderma.

Author Affiliations
ROCHESTER, MINN

Section of Dermatology, Mayo Clinic and Mayo Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Generalized Scleroderma: Treatment With an Immunosuppressive Agent
Jansen et al.
Arch Dermatol 1968;97:690-698.
ABSTRACT